Showing results (1221-1230 of 11,020) with videos related to
Sort By:
Pageof 1,102
Journal of the National Cancer Institute|August 25, 2009
Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancerDemetrius Albanes, Stephanie J Weinstein, Margaret E Wright, et al.Journal of the National Cancer Institute|October 21, 2009
Pharmacokinetically guided dose adjustment of 5-fluorouracil: a rational approach to improving therapeutic outcomesM Wasif Saif, Adrienne Choma, Salvatore J Salamone, et al.Journal of the National Cancer Institute|October 1, 1977
B-lymphocytes and T-lymphocytes in three types of bovine lymphosarcomaI Takashima, C Olson, D M Driscoll, et al.Journal of the National Cancer Institute|November 1, 1977
Susceptibility of common marmosets (Callithrix jacchus) to oncogenic and attenuated strains of Herpesvirus saimiriJ Wright, L A Falk, L G Wolfe, et al.Journal of the National Cancer Institute|November 1, 1977
High incidence of ependymomas induced by BK virus, a human papovavirus: brief communicationA Corallini, G Barbanti-Brodano, W Bortoloni, et al.Journal of the National Cancer Institute|February 18, 2010
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancerPenelope A Bradbury, Dongsheng Tu, Lesley Seymour, et al.Journal of the National Cancer Institute|February 25, 2010
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysisSimone Mocellin, Sandro Pasquali, Carlo R Rossi, et al.Journal of the National Cancer Institute|September 2, 2016
Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment ToolThomas F Imperiale, Menggang Yu, Patrick O Monahan, et al.Journal of the National Cancer Institute|September 1, 2016
IGF-1R and mTOR Blockade: Novel Resistance Mechanisms and Synergistic Drug Combinations for Ewing SarcomaSalah-Eddine Lamhamedi-Cherradi, Brian A Menegaz, Vandhana Ramamoorthy, et al.Journal of the National Cancer Institute|September 1, 2016
Inactivation of Cancer Mutations Utilizing CRISPR/Cas9Christina Gebler, Tim Lohoff, Maciej Paszkowski-Rogacz, et al.Pageof 1,102